Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the ugly

Eur Respir J. 2016 Dec;48(6):1800-1802. doi: 10.1183/13993003.01208-2016. Epub 2016 Oct 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antitubercular Agents / administration & dosage*
  • Humans
  • Netherlands
  • Practice Guidelines as Topic
  • Retrospective Studies
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

  • Antitubercular Agents